A 44-year-old woman is evaluated during routine follow-up of type 2 diabetes mellitus. She also has hypertension. Current medications are metformin, canagliflozin, lisinopril, and hydrochlorothiazide. On physical examination, vital signs are normal. BMI is 26. Triglyceride level is 165 mg/dL (1.86 mmol/L). Her 10-year risk for atherosclerotic cardiovascular disease is 3.8%. Using shared decision making, the patient opts to follow the recommendation of the American Heart Association/American College of Cardiology for cholesterol management.

Which of the following is the most appropriate treatment?

A High-intensity rosuvastatin

B Icosapent ethyl

C Moderate-intensity rosuvastatin

D Omega-3 fatty acid supplements

Choose an Answer Above

Have your Next Page to see if you're right.

Powered ByCareerCast